Sildenafil as an Eligible Heart Transplantation Therapy for Advanced Heart Failure Associated with Fixed Pulmonary Hypertension.
作者信息
Schwartzmann Pedro
机构信息
Hospital Unimed Ribeirão Preto, Ribeirão Preto, SP - Brasil.
Centro de Pesquisa (CAPED) - Centro Médico RBS, Ribeirão Preto, SP - Brasil.
出版信息
Arq Bras Cardiol. 2021 Feb;116(2):227-228. doi: 10.36660/abc.20200631.
Abstract
摘要
相似文献
1
Sildenafil as an Eligible Heart Transplantation Therapy for Advanced Heart Failure Associated with Fixed Pulmonary Hypertension.
Arq Bras Cardiol. 2021 Feb;116(2):227-228. doi: 10.36660/abc.20200631.
2
Dramatic improvement of clinical and hemodynamic parameters of a heart transplant candidate with sildenafil treatment.
Int J Cardiol. 2015 Apr 15;185:148-9. doi: 10.1016/j.ijcard.2015.03.101. Epub 2015 Mar 10.
3
Rapid improvement of pulmonary hemodynamics following combined tadalafil and inotropic treatment in a patient with pulmonary hypertension secondary to left ventricular dysfunction.
Int J Cardiol. 2016 Jan 15;203:212-3. doi: 10.1016/j.ijcard.2015.10.123. Epub 2015 Oct 17.
4
Sildenafil in heart transplant candidates with pulmonary hypertension.
Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):375-84. doi: 10.1016/j.acvd.2015.01.013. Epub 2015 Apr 25.
5
Taking aim at pulmonary hypertension in heart failure with preserved ejection fraction.
Eur Heart J. 2015 Oct 7;36(38):2574-5. doi: 10.1093/eurheartj/ehv280. Epub 2015 Jul 17.
6
Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantation.
Adv Med Sci. 2020 Sep;65(2):298-303. doi: 10.1016/j.advms.2020.04.002. Epub 2020 May 23.
7
Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
Eur Heart J. 2015 Oct 7;36(38):2565-73. doi: 10.1093/eurheartj/ehv336. Epub 2015 Jul 17.
8
Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.
Eur J Heart Fail. 2017 Jan;19(1):116-125. doi: 10.1002/ejhf.662. Epub 2016 Nov 21.
9
Use of sildenafil for pulmonary hypertension in neonates.
Bol Med Hosp Infant Mex. 2020;77(4):202-206. doi: 10.24875/BMHIM.20000041.
10
Sarcoidosis-associated pulmonary hypertension treated with sildenafil - a case report.
Adv Respir Med. 2017;85(5):258-263. doi: 10.5603/ARM.a2017.0042. Epub 2017 Oct 30.
引用本文的文献
1
Riociguat: An Alternative to Treat Pulmonary Hypertension.
Arq Bras Cardiol. 2022 Jul;119(1):111-112. doi: 10.36660/abc.20220305.
本文引用的文献
1
Long-Term Clinical and Hemodynamic Outcomes after Heart Transplantation in Patients Pre-Treated with Sildenafil.
Arq Bras Cardiol. 2021 Feb;116(2):219-226. doi: 10.36660/abc.20190047.
2
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
Circulation. 2018 May 15;137(20):e578-e622. doi: 10.1161/CIR.0000000000000560. Epub 2018 Apr 12.
3
Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1234-46. doi: 10.1164/rccm.201503-0529OC.
4
Sildenafil in heart transplant candidates with pulmonary hypertension.
Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):375-84. doi: 10.1016/j.acvd.2015.01.013. Epub 2015 Apr 25.
5
Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis.
Int J Cardiol. 2014 Oct 20;176(3):595-9. doi: 10.1016/j.ijcard.2014.08.072. Epub 2014 Aug 16.
6
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
JAMA. 2013 Mar 27;309(12):1268-77. doi: 10.1001/jama.2013.2024.
7
Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
J Heart Lung Transplant. 2012 Dec;31(12):1281-7. doi: 10.1016/j.healun.2012.09.009. Epub 2012 Nov 3.
8
The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study.
Int J Cardiol. 2013 Sep 20;168(1):60-5. doi: 10.1016/j.ijcard.2012.09.074. Epub 2012 Oct 8.
9
Pulmonary pressures and death in heart failure: a community study.
J Am Coll Cardiol. 2012 Jan 17;59(3):222-31. doi: 10.1016/j.jacc.2011.06.076.
10
Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study.
Eur J Heart Fail. 2012 Jan;14(1):82-90. doi: 10.1093/eurjhf/hfr147. Epub 2011 Nov 7.
Zotero 插件